This article is more than 5 years old. Information may no longer be current.

Healio honors Mental Illness Awareness Week with top psychiatry news

Mental Illness Awareness Week takes place from October 1 to 7.

To honor this observance, Healio.com/Psychiatry gathered the most popular news articles in psychiatry over the last week.

How to distinguish between malingering, genuine psychosis

SAN DIEGO — At a session on detection of malingering mental illness here at the U.S. Psychiatric and Mental Health Congress, Phillip Resnick, MD, professor of psychiatry, Case Western Reserve University, Cleveland, offered tips on how mental health providers can differentiate between patients feigning mental illness and patients with genuine mental illness. Read more

Personality changes do not begin before Alzheimer’s disease onset

Changes in personality, specifically neuroticism, conscientiousness and extraversion, did not begin before the onset of mild cognitive impairment or Alzheimer’s disease, according to recent findings. Read more

Preparing for potential PTSD triggers after PBS Vietnam War documentary

PBS recently aired a 10-part documentary on the Vietnam War, titled “The Vietnam War,” produced by Ken Burns and Lynn Novick, that was speculated to trigger traumatic memories for some Vietnam War veterans and cause an increase in individuals seeking treatment for PTSD.

Healio.com/Psychiatry spoke with experts to explore the potential impact of the documentary and how clinicians can prepare for it. Read more

Lithium may provide answer to antidepressant shortcomings

NEW ORLEANS — In a presentation here, S. Nassir Ghaemi, MD, MPH, of Tufts University School of Medicine, discussed shortcomings of antidepressants, as well as the promise of lithium at low doses for suicide prevention in depression. Read more

Galen acquires inhaled treatment for agitation in schizophrenia, bipolar I disorder

Galen US recently announced acquisition of U.S. commercial rights to Adasuve, an orally inhaled form of loxapine, from Alexza Pharmaceuticals for agitation associated with schizophrenia or bipolar I disorder. Read more